Upregulation of SATB1 Is Associated with Prostate Cancer Aggressiveness and Disease Progression

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Shukla, Sanjeev ^a   Sharma, Haripaul ^a   Abbas, Ata ^a   MacLennan, Gregory T ^a   Fu, Pingfu ^a,b   Danielpour, David ^a,b   Gupta, Sanjay ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; SPECIAL AT RICH BINDING PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER INVASION; CELL IMMORTALIZATION; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHENOTYPE; PROSTATE CANCER; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; TUMOR XENOGRAFT; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; BIOPSY; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; HUMANS; MALE; MATRIX ATTACHMENT REGION BINDING PROTEINS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

HUMAN PAPILLOMAVIRUS;

EID: 84872133109     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053527     Document Type: Article

References (39)

1. American Cancer Society. Cancer Facts and Figures 2011. Available: http://www.cancer.org/Cancer/ProstateCancer/index. Accessed 2012 August 6.
2. Hsiao W, Moses KA, Goodman M, Jani AB, Rossi PJ, et al. (2010) Stage IV prostate cancer: survival differences in clinical T4, nodal and metastatic disease. J Urol 184: 512-518.
3. Sun Y, Wang BE, Leong KG, Yue P, Li L, et al. (2012) Androgen deprivation causes epithelial-mesenchymal transition in the prostate: Implications for androgen-deprivation therapy. Cancer Res 72: 1-10.
4. Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, et al. (2007) Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 7: 246-255.
5. Tsuji T, Ibaragi S, Hu GF, (2009) Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 69: 7135-7139.
6. Thompson EW, Williams ED, (2008) EMT and MET in carcinoma-clinical observations, regulatory pathways and new models. Clin Exp Metastasis 25: 591-592.
7. Wells A, Yates C, Shepard CR, (2008) E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis 25: 621-628.
8. Veveris-Lowe TL, Lawrence MG, Collard RL, Bui L, Herington AC, et al. (2005) Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Endocr Relat Cancer 12: 631-643.
9. Kim JH, Dhanasekaran SM, Mehra R, Tomlins SA, Gu W, et al. (2007) Integrative analysis of genomic aberrations associated with prostate cancer progression. Cancer Res 67: 8229-8239.
10. Nakagomi K, Kohwi Y, Dickinson LA, Kohwi-Shigematsu T, (1994) A novel DNA-binding motif in the nuclear matrix attachment DNA-binding protein SATB1. Mol Cell Biol 14: 1852-1860.
11. Cunningham JM, Purucker ME, Jane SM, Safer B, Vanin EF, et al. (1994) The regulatory element 3′ to the A gamma-globin gene binds to the nuclear matrix and interacts with special A-T-rich binding protein 1 (SATB1), an SAR/MAR-associating region DNA binding protein. Blood 84: 1298-1308.
12. Notani D, Limaye AS, Kumar PP, Galande S, (2010) Phosphorylation-dependent regulation of SATB1, the higher-order chromatin organizer and global gene regulator. Methods Mol Biol 647: 317-335.
13. Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T, (2002) SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419: 641-645.
14. Savarese F, Dávila A, Nechanitzky R, De La Rosa-Velazquez I, Pereira CF, et al. (2009) Satb1 and Satb2 regulate embryonic stem cell differentiation and Nanog expression. Genes Dev 23: 2625-2638.
15. Ramakrishnan M, Liu WM, DiCroce PA, Posner A, Zheng J, et al. (2000) Modulated binding of SATB1, a matrix attachment region protein, to the AT-rich sequence flanking the major breakpoint region of BCL2. Mol Cell Biol 20: 868-877.
16. Gong F, Sun L, Wang Z, Shi J, Li W, et al. (2011) The BCL2 gene is regulated by a special AT-rich sequence binding protein 1-mediated long range chromosomal interaction between the promoter and the distal element located within the 3′-UTR. Nucleic Acids Res 3: 4640-4652.
17. Szemes M, Gyorgy A, Paweletz C, Dobi A, Agoston DV, (2006) Isolation and characterization of SATB2, a novel AT-rich DNA binding protein expressed in development- and cell-specific manner in the rat brain. Neurochem Res 3: 237-246.
18. Chen H, Takahara M, Oba J, Xie L, Chiba T, et al. (2011) Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. J Dermatol Sci 64: 39-44.
19. Zhao XD, Ji WY, Zhang W, He LX, Yang J, et al. (2010) Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 72: 1-5.
20. Yanagisawa J, Ando J, Nakayama J, Kohwi Y, Kohwi-Shigematsu T, (1996) A matrix attachment region (MAR)-binding activity due to a p114 kilodalton protein is found only in human breast carcinomas and not in normal and benign breast disease tissues. Cancer Res 56: 457-62.
21. Meng WJ, Yan H, Zhou B, Zhang W, Kong XH, et al. (2012) Correlation of SATB1 overexpression with the progression of human rectal cancer. Int J Colorectal Dis 27: 143-50.
22. Zhou LY, Liu F, Tong J, Chen QQ, Zhang FW, (2009) Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer. Nan Fang Yi Ke Da Xue Xue Bao 29: 534-537.
23. Zhao XL, Wang P, (2011) Expression of SATB1 and BRMS1 in ovarian serous adenocarcinoma and its relationship with clinieopathological features. Sichuan Da Xue Xue Bao Yi Xue Ban 42: 82-85.
24. Kuo TC, Chao CC, (2010) Hepatitis B virus X protein prevents apoptosis of hepatocellular carcinoma cells by upregulating SATB1 and HURP expression. Biochem Pharmacol 80: 1093-1102.
25. Lu X, Cheng C, Zhu S, Yang Y, Zheng L, et al. (2010) SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep 24: 981-987.
26. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T, (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452: 187-193.
27. LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, et al. (2002) Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 62: 4499-4506.
28. Stephenson RA, Dinney CP, Gohji K, Ordóñez NG, Killion JJ, et al. (1992) Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 84: 951-957.
29. Zhang C, Soori M, Miles FL, Sikes RA, Carson DD, et al. (2011) Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells. Prostate 71: 157-167.
30. Gingrich JR, Tucker JA, Walther PJ, Day JW, Poulton SH, et al. (1991) Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1). J Urol 146: 915-919.
31. Alvarez JD, Yasui DH, Niida H, Joh T, Loh DY, et al. (2000) The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev 14: 521-535.
32. Glynne R, Ghandour G, Rayner J, Mack DH, Goodnow CC, (2000) B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol Rev 176: 216-246.
33. Cai S, Han HJ, Kohwi-Shigematsu T, (2003) Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 34: 42-51.
34. Selinger CI, Cooper WA, Al-Sohaily S, Mladenova DN, Pangon L, et al. (2011) Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. J Thorac Oncol 6: 1179-1189.
35. Iorns E, Hnatyszyn HJ, Seo P, Clarke J, Ward T, et al. (2010) The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst 102: 1284-1296.
36. Li QQ, Chen ZQ, Cao XX, Xu JD, Xu JW, et al. (2011) Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells. Cell Death Differ 18: 16-25.
37. Li QQ, Chen ZQ, Xu JD, Cao XX, Chen Q, et al. (2010) Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells. Cancer Sci 101: 80-6.
38. Barboro P, Repaci E, D'Arrigo C, Balbi C, (2012) The role of nuclear matrix proteins binding to matrix attachment regions (Mars) in prostate cancer cell differentiation. PLoS One 7: e40617.
39. Notani D, Gottimukkala KP, Jayani RS, Limaye AS, Damle MV, et al. (2010) Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner. PLoS Biol 8: e1000296.